What do longitudinal health studies reveal about the long-term bone density impacts of using Depo-Provera injections for more than the recommended two-year black box warning limit?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What do longitudinal health studies reveal about the long-term bone density impacts of using Depo-Provera injections for more than the recommended two-year black box warning limit?
1 real search · 1 real-search pass
Depo-Provera DMPA long-term use bone mineral density longitudinal study recovery fracture risk beyond 2 years FDA black box ACOG WHO 2024Google ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 1 queries…
Searches and sources
ChatGPT1 real searches · gpt-6
Depo-Provera DMPA long-term use bone mineral density longitudinal study recovery fracture risk beyond 2 years FDA black box ACOG WHO 2024 Google ↗
- Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate · pubmed.ncbi.nlm.nih.gov
- Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate · pubmed.ncbi.nlm.nih.gov
- DailyMed - MEDROXYPROGESTERONE ACETATE injection, suspension · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION safely and effectively. See full prescribing information for MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION. MEDROXYPROGESTERONE ACETATE injectable suspension, for intramuscular use Initial U.S. Approval: 1959 · dailymed.awsprod.nlm.nih.gov
- These highlights do not include all the information needed to use DEPO-PROVERA CI safely and effectively. See full prescribing information for DEPO-PROVERA CI. DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use Initial U.S. Approval: 1959 · dailymed.nlm.nih.gov
- labeling.pfizer.com · labeling.pfizer.com
- Depot Medroxyprogesterone Acetate, Oral Contraceptive, Intrauterine Device Use, and Fracture Risk · pubmed.ncbi.nlm.nih.gov
- Bone Mineral Density Changes Associated With Pregnancy, Lactation, and Medical Treatments in Premenopausal Women and Effects Later in Life · pmc.ncbi.nlm.nih.gov
- Depot Medroxyprogesterone Acetate and Bone Effects · acog.org